Xtx Topco LTD Foghorn Therapeutics Inc. Transaction History

Xtx Topco LTD

$710 Million
Q1 2024

A detailed history of Xtx Topco LTD transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 13,448 shares of FHTX stock, worth $64,550. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,448

Holding current value

$64,550

% of portfolio

0.01%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 13, 2024	BUY	$2.82 - $7.94 $37,923 - $106,777	13,448 New	13,448 $90,000
Q2 2022 Aug 15, 2022	BUY	$8.48 - $16.84 $96,977 - $192,582	11,436 New	11,436 $156,000

Others Institutions Holding FHTX

# of Institutions

Shares Held

23.6M

Call Options Held

7.7K

Put Options Held

1.4K

Flagship Pioneering Inc. Cambridge, MA

12.7M
Shares

$60.8 Million
5.6% of portfolio
Raymond James & Associates St Petersburg, FL

2.23M
Shares

$10.7 Million
0.01% of portfolio
Euclidean Capital LLC New York, NY

1.57M
Shares

$7.55 Million
1.36% of portfolio
Black Rock Inc. New York, NY

1.32M
Shares

$6.31 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.1M
Shares

$5.29 Million
0.0% of portfolio

View Full List

About Foghorn Therapeutics Inc.

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $200M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

More about FHTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account